| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JXSL2400078 | Anifrolumab注射液 | anifrolumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-04-20 | view | ||||
| JXSB2400013 | Anifrolumab注射液 | anifrolumab | Injection | Biological Products(2.2) | Supplementary Application | 2024-02-05 | view | ||||
| JXSL2300160 | Anifrolumab注射液 | anifrolumab | Injection | Biological Products(2.2) | Import Drug Application | 2023-09-01 | view | ||||
| JXSL2300135 | Anifrolumab注射液 | anifrolumab | Injection | Biological Products(2.2) | Import Drug Application | 2023-07-22 | view | ||||
| JXSL2300115 | Anifrolumab注射液 | anifrolumab | Injection | Biological Products(2.2) | Import Drug Application | 2023-06-27 | view | ||||
| JXSL2300092 | Anifrolumab注射液 | anifrolumab | Injection | Biological Products(2.2) | Import Drug Application | 2023-05-12 | view | ||||
| JXSL2101106 | Anifrolumab注射液 | anifrolumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-09-02 | view | ||||
| JXSL2000211 | Anifrolumab注射液 | anifrolumab | Injection | Biological Products(1) | Import Drug Application | 2020-12-14 | AstraZeneca AB | AstraZeneca AB | In Review | 2020-12-03 | view |
| JXSL1600060 | Anifrolumab注射液 | anifrolumab | Injection | Biological Products | Import Drug Application | 2016-11-10 | Medimmune LLC | Certificate Issued | 2017-11-01 | view |